Australia markets close in 6 hours

Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
12.13-0.36 (-2.88%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
742,957
727,406
738,019
789,733
867,315
Cost of revenue
621,109
610,951
607,173
561,272
393,735
Gross profit
121,847
116,455
130,846
228,461
473,579
Operating expenses
Research development
41,629
42,925
37,418
39,643
35,686
Selling general and administrative
29,383
29,353
27,282
47,367
82,262
Total operating expenses
121,026
119,206
108,645
152,259
192,219
Operating income or loss
820.925
-2,751
22,201
76,202
281,360
Interest expense
1,960
1,537
4,559
5,759
4,644
Income before tax
-43,314
-45,308
36,524
80,042
223,674
Income tax expense
8,855
8,894
6,085
8,219
33,702
Income from continuing operations
-52,169
-54,202
30,439
71,822
189,972
Net income
-53,741
-54,063
31,484
75,756
197,438
Net income available to common shareholders
-53,741
-54,063
31,484
75,756
197,438
Basic EPS
-0.11
-0.32
0.18
0.44
1.17
Diluted EPS
-0.11
-0.32
0.18
0.44
1.17
Basic average shares
185,456
168,947
174,913
172,174
168,751
Diluted average shares
185,456
168,947
174,913
172,174
168,751